Jun 1, 2009 | Buzzle.com
Massage Chairs Assist Edema Sufferers
Edeman sufferers can have swelling in the lower legs causing discomfort. Many are finding relief with a massage chair.
Angiogenesis inhibitor improves brain tumor survival by reducing edema
The beneficial effects of anti-angiogenesis drugs in the treatment of the deadly brain tumors called glioblastomas appear to result primarily from reduction of edema - the swelling of brain tissue - and not from any direct anti-tumor effect, according to a study from Massachusetts General Hospital researchers.
Summit County residents more prone to deadly illness
ENLARGE Re-entrant pulmonary edema, which mysteriously and most frequently strikes older children and teens who are returning to their high-elevation homes after trips to sea level, can be treated with oxygen ...
X-GEN Pharmaceuticals Receives FDA Approval For AcetaZOLAMIDE For Injection USP
Main Category: Cardiovascular / Cardiology Also Included In: Regulatory Affairs / Drug Approvals X-GEN Pharmaceuticals announced that it will begin marketing Acetazolamide for Injection USP.
X-GEN gets FDA nod to market AcetaZOLAMIDE for Injection USP
The product is AP rated and equivalent to Diamox by Duramed Pharmaceuticals. AcetaZOLAMIDE for Injection USP is indicated for adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; ...
X-GEN Pharmaceuticals Receives FDA Approval for AcetaZOLAMIDE for Injection USP
The product is AP rated and equivalent to Diamox by Duramed Pharmaceuticals. Acetazolamide for Injection USP is indicated for adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; ...
Why Climbers Die On Mount Everest
A team of researchers examined Why Climbers Die On Mount Everest : The overall mortality rate for Everest mountaineers during the entire 86-year period was 1.3 percent; the rate among climbers was 1.6 percent ...
More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling...
More than 200 abstracts from therapies across the Novartis Oncology portfolio will be presented at two December medical congresses, providing new data and profiling potential patient benefits from ongoing ...